PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
Corporate Actions

Glenmark Pharmaceuticals Limited

In PositoAI's records, Glenmark Pharmaceuticals Limited has had 7 dividends since 2021 (₹17.5 per share in total). Latest dividend: ₹2.5 per share, ex-date 31 Aug 2026.

Records start: dividends 2021, bonus and rights issues 2016, splits and buybacks 2022, mergers and demergers 2025. Earlier actions are not shown.

Glenmark Pharmaceuticals Limited Dividend History#

Ex-dateDividendRecord dateAnnounced
2026₹2.5 per share
31 Aug 2026₹2.5 per share31 Aug 202629 May 2026
2025₹5 per share (2 payments)
15 Sep 2025₹2.5 per share15 Sep 202523 May 2025
3 Oct 2025₹2.5 per share3 Oct 202526 Sep 2025
2024₹2.5 per share
13 Sep 2024₹2.5 per share17 Sep 202424 May 2024
2023₹2.5 per share
18 Sep 2023₹2.5 per share19 Sep 202319 May 2023
2022₹2.5 per share
12 Sep 2022₹2.5 per share14 Sep 202228 May 2022
2021₹2.5 per share
8 Sep 2021₹2.5 per share10 Sep 202128 May 2021

Amounts are per share as declared, not adjusted for later bonus issues or splits.

Questions

Does Glenmark Pharmaceuticals Limited pay dividends?

Yes. In PositoAI's records (from 2021), Glenmark Pharmaceuticals Limited has paid 7 dividends, the latest ₹2.5 per share with ex-date 31 August 2026.

How much dividend did Glenmark Pharmaceuticals Limited pay in 2025?

₹5 per share in 2025, in 2 payments.

What is an ex-date and a record date?

To receive a dividend, bonus or other benefit, you must own the shares before the ex-date. The record date is the day the company checks its list of shareholders.

Records: dividends from 2021, bonus issues and rights issues from 2016, splits and buybacks from 2022, mergers and demergers from 2025; new actions are added every day. Amounts are per share in rupees. To receive a dividend or bonus, shares must be held before the ex-date. Please confirm dates with the company's own announcement. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.